Abstract:GNE myopathy is a rare autosomal recessive disorder caused by mutations in the GNE gene, which is essential for the sialic acid biosynthesis pathway. Although over 200 GNE variants have been reported, some patients remain undiagnosed with only one heterozygous mutation. This study aims to analyse the entire GNE genomic region to identify novel mutations. Patients with clinically compatible GNE myopathy and mono-allelic mutations in the GNE gene were enrolled. The other GNE mutation was searched using a combination of Sanger sequencing, targeted next-generation sequencing (NGS), exon2 qPCR, and Nanopore long-read single-molecule sequencing (LRS). Verification of pseudoexons was performed by RT-PCR and sequencing of complementary DNA (cDNA) derived from frozen skeletal muscle tissue. Ten patients were enrolled, who exhibited typical symptoms, such as foot drop, walking difficulty, or distal weakness affecting both hands and lower legs. Three patients had idiopathic thrombocytopenia (ITP) and one had increased platelet count. The median age at onset was 33 years (25-44 years). A novel deep intronic variant (DIV), c.862+870C>T, was detected in nine patients from eight unrelated families. It was predicted by SpliceAI to create new splice donor sites and lead to pseudoexon inclusion. Splice-site strength scoring methods supported these predictions, indicating high probabilities of abnormal splicing. RT-PCR and sequencing of cDNA derived from muscle tissues revealed a 146 bp inserted fragment between GNE exon 5 and 6, which would result in a premature stop codon. RNA sequencing confirmed abnormal GNE splicing and expression, causing the inclusion of a pathogenic pseudoexon in GNE mRNA. This study identified a novel deep intronic disease-causing mutation in the GNE gene. It located at the allosteric region of the UDP-GlcNAc-2-epimerase (GNE) domain, which is also associated with ITP. Further research is necessary to better understand the molecular mechanisms underlying thrombocytopenia resulted from this mutation. The discovery of novel mutations in GNE, such as the deep intronic mutation activating pseudoexon inclusion, expanded the mutational spectrum of GNE myopathy. A modified genetic test algorithm covering the entire region of GNE gene will optimize the molecular diagnosis in the future. GNE myopathy is a rare autosomal recessive disorder caused by mutations in the GNE gene, which is essential for the sialic acid biosynthesis pathway. Although over 200 GNE variants have been reported, some patients remain undiagnosed with only one heterozygous mutation. This study aims to analyse the entire GNE genomic region to identify novel mutations. Patients with clinically compatible GNE myopathy and mono-allelic mutations in the GNE gene were enrolled. The other GNE mutation was searched using a combination of Sanger sequencing, targeted next-generation sequencing (NGS), exon2 qPCR, and Nanopore long-read single-molecule sequencing (LRS). Verification of pseudoexons was performed by RT-PCR and sequencing of complementary DNA (cDNA) derived from frozen skeletal muscle tissue. Ten patients were enrolled, who exhibited typical symptoms, such as foot drop, walking difficulty, or distal weakness affecting both hands and lower legs. Three patients had idiopathic thrombocytopenia (ITP) and one had increased platelet count. The median age at onset was 33 years (25-44 years). A novel deep intronic variant (DIV), c.862+870C>T, was detected in nine patients from eight unrelated families. It was predicted by SpliceAI to create new splice donor sites and lead to pseudoexon inclusion. Splice-site strength scoring methods supported these predictions, indicating high probabilities of abnormal splicing. RT-PCR and sequencing of cDNA derived from muscle tissues revealed a 146 bp inserted fragment between GNE exon 5 and 6, which would result in a premature stop codon. RNA sequencing confirmed abnormal GNE splicing and expression, causing the inclusion of a pathogenic pseudoexon in GNE mRNA. This study identified a novel deep intronic disease-causing mutation in the GNE gene. It located at the allosteric region of the UDP-GlcNAc-2-epimerase (GNE) domain, which is also associated with ITP. Further research is necessary to better understand the molecular mechanisms underlying thrombocytopenia resulted from this mutation. The discovery of novel mutations in GNE, such as the deep intronic mutation activating pseudoexon inclusion, expanded the mutational spectrum of GNE myopathy. A modified genetic test algorithm covering the entire region of GNE gene will optimize the molecular diagnosis in the future.

Novel GNE missense variants impair de novo sialylation and cause defective angiogenesis in the developing brain in mice

Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis

Lysosomal sialidase NEU1, its intracellular properties, deficiency, and use as a therapeutic agent

GNE deficiency impairs Myogenesis in C2C12 cells and cannot be rescued by ManNAc supplementation

Compound Heterozygous Mutations in the Neuraminidase 1 Gene in Type 1 Sialidosis: A Case Report and Review of Literature

Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopenia

Glutaminase C Overexpression in the Brain Induces Learning Deficits, Synaptic Dysfunctions, and Neuroinflammation in Mice.

P160 A Deep Intronic Variant C.862+870c>t Correlated with GNE Myopathy and Thrombocytopenia

Glycation Interferes with the Activity of the Bi-Functional UDP- N-Acetylglucosamine 2-Epimerase/ N-Acetyl-mannosamine Kinase (GNE)

Defect in cytosolic Neu2 sialidase abrogates lipid metabolism and impairs muscle function in vivo

Induced Muscle and Liver Absence of Gne in Postnatal Mice Does Not Result in Structural or Functional Muscle Impairment

Novel Compound Heterozygous Mutations in a GNE Myopathy with Congenital Thrombocytopenia: A Case Report and Literature Review.

Neurodevelopmental Defects in Human Cortical Organoids with N-acetylneuraminic Acid Synthase Mutation.

N -acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function

Neuronal loss of Impairs O-glycosylation and Leads to Neurobehavioral Deficits Mimicking GALNT2-CDG

A novel mutation alters GNE bifunctional enzyme activity and leads to familial inherited GNE diseases

Compound heterozygous mutations of NTNG2 cause intellectual disability via inhibition of the CaMKII signaling

Evaluation of N-Acetylmannosamine Administration to Restore Sialylation in GNE-Deficient Human Embryonal Kidney Cells

A novel variant in SMG9 causes intellectual disability, confirming a role for nonsense-mediated decay components in neurocognitive development

Novel NGLY1 gene variants in Chinese children with global developmental delay, microcephaly, hypotonia, hypertransaminasemia, alacrimia, and feeding difficulty

Severe Congenital Thrombocytopenia Characterized by Decreased Platelet Sialylation and Moderate Complement Activation Caused by Novel Compound Heterozygous Variants in GNE